Sterile Medical Packaging Market Report 2026

The sterile medical packaging market size has grown rapidly in recent years. It will grow from $57.41 billion in 2025 to $64.66 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to rising pharmaceutical production volumes, expansion of medical device manufacturing, increasing use of single-use medical products, growth in hospital and healthcare infrastructure, tightening sterility and safety standards.

The sterile medical packaging market size is expected to see rapid growth in the next few years. It will grow to $104.36 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to increasing demand for biologics and injectable drugs, rising focus on sustainable sterile packaging materials, expansion of contract packaging services, growing adoption of smart packaging technologies, increasing regulatory scrutiny on packaging integrity. Major trends in the forecast period include increasing adoption of advanced barrier materials, rising demand for high-integrity sterile packaging solutions, growing use of pre-fillable and ready-to-use packaging, expansion of automated sterile packaging lines, enhanced focus on regulatory-compliant packaging designs.

The rising number of hospitals is expected to drive the growth of the sterile medical packaging market. Hospitals, as facilities providing medical and surgical care to patients, rely heavily on sterile packaging to maintain the safety, sterility, and integrity of medical devices and equipment. For instance, in 2024, according to the American Hospital Association, a US-based non-profit organization, the total number of hospitals in the United States reached 6,120, up from 6,093 in 2022. This increase in healthcare facilities is creating higher demand for sterile medical packaging solutions to support safe and effective patient care.

Key companies in the sterile medical packaging market are concentrating on developing recyclable thermoforming films to enhance barrier properties and minimize waste, ensuring that medical devices and pharmaceuticals retain their sterility and integrity throughout their lifecycle. Recyclable thermoforming film refers to specialized plastic films that are shaped and formed through a heating process to create protective packaging for medical devices, equipment, and products. This film is compatible with various sterilization methods, including ethylene oxide (EO), plasma, and gamma irradiation, which is essential for maintaining the sterility of medical devices. For instance, in November 2023, Coveris Inc., an Austria-based packaging company, introduced Formpeel P, a recyclable thermoforming film designed to be environmentally friendly and aligned with Coveris's commitment to sustainability and waste reduction in packaging solutions. Depending on its intended application, Formpeel P can be used on a peelable polyethylene (PE) or polyolefin (PO) base, providing flexibility to meet a variety of medical packaging requirements.

In June 2024, Sterimed S.A., a France-based provider of sterile medical packaging solutions, acquired Riverside Medical Packaging Ltd., a UK-based provider of sterilization-packaging systems, for an undisclosed amount. With this acquisition, Sterimed aimed to expand its capabilities into advanced contract packing, clean-room assembly, and device-kit manufacturing, strengthening its integrated sterile-packaging service offerings for medical device manufacturers and enhancing its position in the global sterile medical packaging market.

Major companies operating in the sterile medical packaging market are Amcor Limited, DuPont De Nemours and Company, 3M Company, West Pharmaceutical Services Inc., Oliver Healthcare Packaging LLC, Placon Corporation, Riverside Medical Packaging Company Ltd., Wipak Group, Steripack Ltd., Techinipaq Inc., GS Medical Packaging Inc., Sonoco Products Company, Nelipak Healthcare Packaging, Berry Global Inc., Gerresheimer AG, Schott AG, Bemis Company Inc., Mitsubishi Chemical Holdings Corporation, UFP Technologies Inc., Klockner Pentaplast Group.

North America was the largest region in the sterile medical packaging market share in 2025. The regions covered in the sterile medical packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sterile medical packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sterile medical packaging market includes revenues earned by entities by sterilizing medical goods such as syringes, needles, vials, and medical instruments to protect from microbial contamination. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.